Clinical Cancer Research AACR Conference on Cancer Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 5995-6000, October 15, 2007. doi: 10.1158/1078-0432.CCR-07-0729
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vucic, D.
Right arrow Articles by Fairbrother, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vucic, D.
Right arrow Articles by Fairbrother, W. J.

Molecular Pathways

The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer

Domagoj Vucic and Wayne J. Fairbrother

Authors' Affiliation: Department of Protein Engineering, Genentech, Inc., South San Francisco, California

Requests for reprints: Wayne J. Fairbrother, Department of Protein Engineering, Genentech, Inc., South San Francisco, CA 94080. Phone: 650-225-6372; Fax: 650-225-3734; E-mail: fairbro{at}gene.com.

Abstract

Apoptosis is a cell suicide process with a major role in development and homeostasis in vertebrates and invertebrates. Inhibition of apoptosis enhances the survival of cancer cells and facilitates their escape from immune surveillance and cytotoxic therapies. Among the principal molecules contributing to this phenomenon are the inhibitor of apoptosis (IAP) proteins, a family of antiapoptotic regulators that block cell death in response to diverse stimuli through interactions with inducers and effectors of apoptosis. IAP proteins are expressed in the majority of human malignancies at elevated levels and play an active role in promoting tumor maintenance through the inhibition of cellular death and participation in signaling pathways associated with malignancies. Here, we discuss the role of IAP proteins in cancer and options for targeting IAP proteins for therapeutic intervention.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Vogler, H. Walczak, D. Stadel, T. L. Haas, F. Genze, M. Jovanovic, J. E. Gschwend, T. Simmet, K.-M. Debatin, and S. Fulda
Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo
Cancer Res., October 1, 2008; 68(19): 7956 - 7965.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. J. Schile, M. Garcia-Fernandez, and H. Steller
Regulation of apoptosis by XIAP ubiquitin-ligase activity
Genes & Dev., August 15, 2008; 22(16): 2256 - 2266.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. N. Dynek, S. M. Chan, J. Liu, J. Zha, W. J. Fairbrother, and D. Vucic
Microphthalmia-Associated Transcription Factor Is a Critical Transcriptional Regulator of Melanoma Inhibitor of Apoptosis in Melanomas
Cancer Res., May 1, 2008; 68(9): 3124 - 3132.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.